Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Valneva SE

Start price
Target price
Perf. (%)
€13.84
25.08.21
-
25.08.22
-32.23%
26.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.72
11.09.21
€30.00
11.09.22
-38.66%
21.08.22

buy
Theradiag S.A.

Start price
Target price
Perf. (%)
€1.90
16.08.21
€2.40
16.08.22
-14.53%
17.08.22

Crossject S.A.

Start price
Target price
Perf. (%)
€2.82
18.11.21
€2.50
18.11.22
66.84%
16.08.22

Could be worthwhile Investment >10% per year
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€39.16
23.02.22
-
23.02.23
-33.30%
13.08.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€29.96
30.11.21
€35.00
30.11.22
-66.46%
12.08.22

Could be very worthwhile Investment >20% year
buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€154.40
23.07.22
€170.00
23.08.22
5.63%
11.08.22

Could be very worthwhile Investment >20% year
Innovative
Sustainability is important
Small cyclical dependencies
buy
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.48
30.11.21
-
30.11.22
-50.67%
10.08.22

Could be worthwhile Investment >10% per year
buy
Cellectis Nom.

Start price
Target price
Perf. (%)
€9.20
15.10.21
€11.50
15.10.22
-61.67%
07.08.22

Could be worthwhile Investment >10% per year
buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€146.15
15.07.22
€155.00
15.07.23
5.64%
23.07.22

Could be very worthwhile Investment >20% year
Innovative
Sustainability is important
Small cyclical dependencies
buy
Valneva SE

Start price
Target price
Perf. (%)
€28.32
29.11.21
-
29.11.22
-65.32%
21.07.22

Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
buy
Valneva SE

Start price
Target price
Perf. (%)
€11.85
08.07.21
-
08.07.22
-11.18%
08.07.22

buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€86.85
08.07.21
€115.00
08.07.22
13.32%
08.07.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
Avadel Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€2.22
18.06.22
-
18.06.23
-4.50%
26.06.22

buy
Neovacs

Start price
Target price
Perf. (%)
€528,000
22.06.21
€240,000,000
22.06.22
-99.70%
23.06.22

buy
Avadel Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€2.36
28.05.22
-
28.05.23
-5.93%
18.06.22

DBV Technologies S.A.

Start price
Target price
Perf. (%)
€5.39
09.06.22
-
09.06.23
-18.78%
11.06.22

Avadel Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€2.36
28.05.22
€1.00
28.05.23
-5.93%
11.06.22

buy
Spineway

Start price
Target price
Perf. (%)
€60.00
17.06.21
€400.00
17.06.22
-66.67%
05.06.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€12.30
27.04.22
-
27.05.22
-6.54%
28.05.22

buy
Spineway

Start price
Target price
Perf. (%)
€60.00
22.05.21
€40,000
22.05.22
-66.67%
23.05.22

buy
Abivax S.A.

Start price
Target price
Perf. (%)
€25.50
01.12.21
€28.00
01.12.22
-31.92%
20.05.22

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Edap Tms S.A. ADR

Start price
Target price
Perf. (%)
€5.00
03.01.22
-
03.01.23
27.00%
15.05.22

Probably not worthwhile Investment
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€82.15
14.09.21
€89.00
14.09.22
20.12%
15.05.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€16.80
14.04.22
€30.00
14.05.22
-46.73%
15.05.22